Investing. com – GlaxoSmithKline, Alphabet (NASDAQ:GOOGL) unit create bioelectronics firm.
U.K,’s GSK, Alphabet’s Verify Life to invest $715 mn in Galvani Bioelectronics.
New firm aims to fight diseases by targeting electrical signals in the body.
GSK has 55% stake in Galvani; Verify Life Sciences 45%.
Galvani to be based in GSK’s research center in north of London.